Fast-Growing Telehealth Company SnapMD Lands $7.1 Million to Boost Its Technology Platform, Expand Operations

LOS ANGELES, Sept. 18, 2018 /PRNewswire/ -- SnapMD, an award-winning full-service enterprise telehealth technology innovator and solutions provider, today announced that it has raised $7.1 million in Series B funding, bringing the total capital raised to date to $16.3 million. Participating investors included the original syndicate. The company will use the latest funding to further advance its telemedicine platform and accelerate its sales and marketing efforts.

SnapMD's Virtual Care Management (VCM) telehealth software is a robust digital health system that places the tools of telemedicine in the hands of providers to deliver virtual, high-quality and coordinated care. As a cohesive and complete suite of services in the cloud, the technology enables providers to launch and manage virtual care that can be scaled across a health enterprise and the care continuum. The white-label VCM platform is configured to support multiple hospital and health system service lines with unique operational requirements, and with architecture that can be integrated to work seamlessly with existing and future systems.

SnapMD's VCM platform has been selected by the University of Mississippi Medical Center National Telehealth Center of Excellence as the virtual care technology partner of choice and currently serves as the foundation of the University of San Diego Hahn School of Nursing and Health Science competency-based telehealth curriculum. The VCM is also the preferred telehealth provider of the American Academy of Pediatrics.

"Since our inception, SnapMD has been focused on improving patient care. While a significant amount of attention has been paid to single-episodic, low-acuity care, the higher value of virtual care will target the 20% of Americans that consume 80% of the healthcare dollar—namely, the chronically ill and those in active episodes of treatment, such as cancer. With SnapMD's recognition as the most advanced telemedicine platform in the world, our white-label telehealth solution enables healthcare providers to extend their offerings under their own brand and with their own physicians," said Dave Skibinski, president and CEO of SnapMD. "The new investment allows us to continue to further drive our marketing and business development efforts in support of our rapidly growing provider base across the country."

A recent study by Foley & Lardner LLP stated that 76% of healthcare senior executives have implemented or plan to implement virtual services and telehealth programs. As health systems and provider groups are now focused on value-based care, SnapMD is poised to deliver enterprise support that provides a wide array of services, while maintaining referral mechanisms to streamline and coordinate care. As the market is prepared for broader adoption of telemedicine, SnapMD, with this financing, is well positioned to expand its business development, and sales and marketing programs.

About SnapMD
SnapMD offers the leading enterprise-level Virtual Care Management (VCM) telehealth platform. The full-stack software solution enables healthcare providers to engage their patients via a comprehensive, secure, HIPAA/HITECH/COPPA compliant, cloud-based telemedicine platform with powerful back-end systems to manage the digital health care continuum. SnapMD offers the software and services that healthcare providers need to improve access to convenient and effective care. SnapMD's robust, scalable, private-label VCM platform is designed to handle multiple service-lines and can be deployed as a single telehealth platform across the enterprise. For more information, please visit http://www.snap.md.

Media Contact:
Kay Kelly for SnapMD
[email protected]
401.490.9700

SOURCE SnapMD